Gene · 839
Papers3,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitexin Induces Apoptosis in MCF-7 Breast Cancer Cells through the Regulation of Specific miRNAs Expression. | Int J Mol Cell Med | 2022 | 37605736 | PubTator, text mining | PubMed |
| Making the head: Caspases in life and death. | Front Cell Dev Biol | 2022 | 36712975 | PubTator, text mining | PubMed |
| A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma. | Front Genet | 2022 | 36685978 | PubTator, text mining | PubMed |
| A Novel Pyroptosis-Related Gene Signature for Prediction of Disease-Free Survival in Papillary Thyroid Carcinoma. | J Pers Med | 2022 | 36675746 | PubTator, text mining | PubMed |
| Adlay, an ancient functional plant with nutritional quality, improves human health. | Front Nutr | 2022 | 36618703 | PubTator, text mining | PubMed |
| Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. | Front Immunol | 2022 | 36618366 | PubTator, text mining | PubMed |
| Phenolic Extract from Extra Virgin Olive Oil Induces Different Anti-Proliferative Pathways in Human Bladder Cancer Cell Lines. | Nutrients | 2022 | 36615840 | PubTator, text mining | PubMed |
| Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer. | Molecules | 2022 | 36615305 | PubTator, text mining | PubMed |
| ZBP1-Mediated Necroptosis: Mechanisms and Therapeutic Implications. | Molecules | 2022 | 36615244 | PubTator, text mining | PubMed |
| Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. | Int J Mol Sci | 2022 | 36614089 | PubTator, text mining | PubMed |
| Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma. | Front Oncol | 2022 | 36605437 | PubTator, text mining | PubMed |
| Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective. | Front Immunol | 2022 | 36605187 | PubTator, text mining | PubMed |
| A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Endometrial Cancer. | Dis Markers | 2022 | 36601599 | PubTator, text mining | PubMed |
Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways. | Front Pharmacol | 2022 | 36601056 | PubTator, text mining | PubMed |
| Biological function, mediate cell death pathway and their potential regulated mechanisms for post-mortem muscle tenderization of PARP1: A review. | Front Nutr | 2022 | 36590225 | PubTator, text mining | PubMed |
| Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer's disease analyzed by network pharmacology and molecular docking prediction. | Front Aging Neurosci | 2022 | 36570530 | PubTator, text mining | PubMed |
| Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections. | Front Immunol | 2022 | 36569952 | PubTator, text mining | PubMed |
| Construction of Pyroptosis-Related Prognostic and Immune Infiltration Signature in Bladder Cancer. | Dis Markers | 2022 | 36569221 | PubTator, text mining | PubMed |
| Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment. | Pharmaceutics | 2022 | 36559135 | PubTator, text mining | PubMed |
| Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases. | Pharmaceutics | 2022 | 36559116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/papers?page=21